<DOC>
	<DOCNO>NCT00276393</DOCNO>
	<brief_summary>Patients type 1 diabetes trained multiple daily insulin injection treat two diffferent kind long acting insulin preparation . The two insulin preparation glargine ultralente insulin . Patients randomize receive one two insulin preparation first 4 month follow second preparation four month . Short act insulin use period . We find glargine insulin well ultralente insulin study .</brief_summary>
	<brief_title>Treatment Trial Evaluating Long Acting Insulin Type 1 Diabetes</brief_title>
	<detailed_description>Multiple daily insulin injection ( MDI ) program commonly accompany considerable glycemic variation hypoglycemia . In order determine whether use insulin glargine basal insulin would result comparable HbA1c less glycemic variation hypoglycemia ultralente insulin , 22 individual type 1 diabetes , experience MDI , HbA1c &lt; 7.8 % randomize , receive either glargine ultralente basal insulin 4-months . Aspart insulin use prandial . Physicians provide insulin dose adjustment advice mask type basal insulin . Treatment glargine result low mean HbA1c , less nocturnal variability , less hypoglycemia primarily due less daytime hypoglycemia ( p=0.002 ) . On hand , serious hypoglycemia average glucose concentration measure continuous glucose monitoring system ( CGMS ) differ . We conclude , use either ultralente glargine basal insulin result excellent glycemic control , treatment glargine associate slightly significantly low HbA1C , less nocturnal glycemic variability less hypoglycemia .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetes , HbA1c &lt; 7.8 % , prior instruction complex insulin program , presently use MDI insulin program basal insulin preparation Glargine Ultralente Humalog short act insulin , free hepatorenal abnormality hypoglycemia unawareness ; nonpregnant , able perform frequent self monitoring blood glucose ( SMBG ) accept use continuous glucose monitoring system ( CGMS ) . They also possess skill understanding insulin dose adjustment supplementation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>